Skip to content
Biodatica
Start free

Investigator

Boaz Pirie Levi

ALLEN INSTITUTE · funded by NINDS

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$785k

Summed across those awards.

First award
May 15, 2025

On this record.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R61

    Development of an oligonucleotide therapeutic for Dravet syndrome

    $392k

    May 15, 2025NINDSALLEN INSTITUTENIH RePORTER · 11122651 (opens the source filing in a new tab)

  2. R61

    Development of an oligonucleotide therapeutic for Dravet syndrome

    $393k

    May 15, 2025NINDSALLEN INSTITUTENIH RePORTER · 11330318 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources